Vaccinations
Vaccination Reference Library
Comprehensive guide to adult and pediatric immunizations
Schedule
Annual (everyone >6 months)
Indications
Prevention of seasonal influenza
Contraindications
Severe allergic reaction to previous dose
Notes
Live attenuated (nasal) contraindicated in pregnancy and immunocompromised.
Schedule
Every 10 years (Td or Tdap), 1 dose Tdap for all adults
Indications
Tetanus prophylaxis, wound management, pregnancy (27-36 weeks)
Contraindications
Encephalopathy within 7 days of previous pertussis vaccine
Notes
Tdap recommended for every pregnancy.
Schedule
2 doses (Childhood)
Indications
Immunity against measles, mumps, rubella
Contraindications
Pregnancy, Severe immunodeficiency (Live vaccine)
Notes
Adults without evidence of immunity should get at least 1 dose.
Schedule
2 doses
Indications
Immunity against varicella
Contraindications
Pregnancy, Severe immunodeficiency (Live vaccine)
Notes
Check titers if history uncertain.
Schedule
2 doses separated by 2-6 months
Indications
Adults ≥50 years (regardless of chickenpox history)
Contraindications
Current herpes zoster infection
Notes
Recombinant vaccine, preferred over live Zostavax.
Schedule
Single dose PCV20 OR PCV15 followed by PPSV23
Indications
Adults ≥65, or 19-64 with risk factors
Contraindications
Severe allergic reaction
Notes
Risk factors: Chronic heart/lung/liver/renal disease, diabetes, smoking.
Schedule
Primary series + Boosters as per current CDC guidelines
Indications
Prevention of COVID-19
Contraindications
Severe allergic reaction to component
Notes
Keep updated with latest variant boosters.
Schedule
2 or 3 dose series depending on brand
Indications
All adults 19-59, ≥60 with risk factors
Contraindications
Hypersensitivity to yeast
Notes
Check titers for healthcare workers.
Schedule
2 doses separated by 6-18 months
Indications
Travel, chronic liver disease, MSM, HBV co-infection
Contraindications
Severe allergic reaction
Notes
Rapid schedule available (0, 7, 21-30 days) for urgent travel.
Schedule
3 doses (0, 1-2, 6 months) if age 15+; 2 doses if <15
Indications
Ages 11-26 (standard), up to 45 for catch-up
Contraindications
Severe allergic reaction to vaccine components
Notes
9-valent covers most carcinogenic strains. Can prevent cervical, anal, oropharyngeal cancers.
Schedule
MenACWY: 2 doses (0, 1 yr) or 1 dose; MenB: 2 doses (0, 1 yr)
Indications
Ages 11-35, college students, asplenia, complement deficiency, microbiologists
Contraindications
Severe allergic reaction
Notes
MenB covers serogroup B (responsible for college outbreaks). Give separately from MenACWY.
Schedule
3 doses (ages 2, 4, 6 months) or 2 doses for Rotarix
Indications
All infants
Contraindications
Intussusception history, SCID, severe allergic reaction
Notes
Oral vaccine. Must complete series before 8 months of age.
Schedule
4 doses (2, 4, 6-18 months, 4-6 years)
Indications
All children, unvaccinated adults
Contraindications
Severe allergic reaction to neomycin/streptomycin
Notes
US uses inactivated vaccine (IPV). Booster for travelers to endemic areas.
Schedule
See Tdap above
Indications
See Tdap above
Contraindications
See Tdap above
Notes
Most adults receive Tdap as adult form; children receive DTaP series.
Schedule
3 doses (2, 4, 6 months) + booster (12-15 months)
Indications
All children; adults with asplenia, complement deficiency
Contraindications
Severe allergic reaction
Notes
Major cause of meningitis in unvaccinated children.
Schedule
PCV13 (children), PCV20 or PCV15+PPSV23 (adults ≥65 or risk factors)
Indications
All children <5, adults ≥65, chronic disease, asplenia, smoking
Contraindications
Severe allergic reaction
Notes
Covers 13-20 serotypes. PPSV23 for older vaccines/asplenic patients.
Schedule
See MMR above
Indications
See MMR above
Contraindications
See MMR above
Notes
Highly contagious. Immunity critical for healthcare workers and travelers.
Schedule
See Varicella above
Indications
See Varicella above
Contraindications
See Varicella above
Notes
Can cause zoster (shingles) reactivation in immunocompromised.
Schedule
2 doses separated by 28 days
Indications
Travel to endemic areas (Asia), research workers
Contraindications
Severe allergic reaction, Guillain-Barré history
Notes
Consider if >1 month in endemic areas. Vero cell vaccine highly effective.
Schedule
Single dose (booster every 30 years if high-risk exposure)
Indications
Travel to endemic areas (Africa, South America)
Contraindications
Age <6 months, severe immunodeficiency, egg allergy
Notes
One of most effective vaccines (95% protection). Certificate required for travel to some countries.
Schedule
3 doses pre-exposure (0, 7, 21-28 days); post-exposure varies by exposure type
Indications
High-risk occupations (veterinarians, zookeepers), animal exposure, travelers to high-risk areas
Contraindications
Severe allergic reaction
Notes
100% effective if given before symptom onset. Post-exposure prophylaxis = vaccine + rabies immunoglobulin.
Schedule
1 dose (inactivated); 4 capsules (oral) every other day x 4
Indications
Travel to endemic areas, high-risk contacts
Contraindications
Severe allergic reaction, fever (oral vaccine)
Notes
Oral vaccine less effective. Parenteral typhoid combined with hepatitis A available (Vivaxim).
Schedule
Single dose (1-2 weeks before travel)
Indications
Travel to endemic areas (rarely needed in developed countries)
Contraindications
Hypersensitivity to ingredients, significant GI disease
Notes
Oral vaccine. Protects ~90% against Vibrio cholerae for 3 years.
Schedule
See Tdap above
Indications
See Tdap above
Contraindications
See Tdap above
Notes
In Tdap (acellular) form. Associated with fewer side effects than whole-cell vaccine.
Schedule
2-3 doses depending on brand
Indications
All infants (critical in first 6 months of life)
Contraindications
Intussusception history, SCID
Notes
Oral vaccine. Provides excellent protection (>90%) against severe gastroenteritis.
Schedule
Not currently available (withdrawn from market)
Indications
Was for endemic areas (Northeast US, Wisconsin, Minnesota)
Contraindications
N/A
Notes
Vaccine withdrawn in 2002 due to public concerns, though safety was supported by evidence.
Schedule
2 doses separated by 2-4 weeks (subcutaneous)
Indications
Orthopoxvirus exposure, high-risk contacts, travelers to endemic areas
Contraindications
Severe immunodeficiency, severe allergic reaction
Notes
Newer vaccine for monkeypox with fewer side effects than older vaccines.
Schedule
Single dose (newly approved for adults ≥60)
Indications
Adults ≥60, especially those at risk for severe RSV disease
Contraindications
Severe allergic reaction
Notes
New vaccine approved 2023. Reduces RSV LRTI by 70-80% in older adults.
Schedule
See Smallpox/Monkeypox above
Indications
See Smallpox/Monkeypox above
Contraindications
See Smallpox/Monkeypox above
Notes
Same vaccine as smallpox. Originally developed for smallpox, provides cross-protection.
Created by Safana Abdullah
For educational purposes only. Always consult a medical professional for diagnosis and treatment.
